Antares Pharma

$4.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.22%) Today
+$0.01 (+0.22%) As of 12:20 PM UTC after-hours

Why Robinhood?

You can buy or sell Antares Pharma and other stocks, options, and ETFs commission-free!

About ATRS

Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. The listed name for ATRS is Antares Pharma, Inc. Common Stock.

CEO
Robert F. Apple
Employees
178
Headquarters
Ewing, New Jersey
Founded
1979
Market Cap
738.37M
Price-Earnings Ratio
80.72
Dividend Yield
—
Average Volume
1.88M
High Today
$4.51
Low Today
$4.40
Open Price
$4.41
Volume
1.60M
52 Week High
$5.07
52 Week Low
$1.60

ATRS Earnings

-$0.04
-$0.02
$0.01
$0.03
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 2, Pre-Market

You May Also Like

ANSS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure